Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study) ...

Abstract Background The complex management of health needs in multimorbid patients, alongside limited cost data, presents challenges in developing cost-effective patient-care pathways. We estimated the costs of managing 171 dyads and 969 triads in Belgium, taking into account the influence of morbidity interactions on costs. Methods We followed a retrospective longitudinal study design, using the linked Belgian Health Interview Survey 2018 and the administrative claim database 2017–2020 hosted by the Intermutualistic Agency. We included people aged 15 and older, who had complete profiles (N =... Mehr ...

Verfasser: Tran, Phuong Bich
Nikolaidis, Georgios F.
Abatih, Emmanuel
Bos, Philippe
Berete, Finaba
Gorasso, Vanessa
Van der Heyden, Johan
Kazibwe, Joseph
Tomeny, Ewan Morgan
Van Hal, Guido
Beutels, Philippe
van Olmen, Josefien
Dokumenttyp: Datenquelle
Erscheinungsdatum: 2024
Verlag/Hrsg.: figshare
Schlagwörter: Medicine / Sociology / FOS: Sociology / Biological Sciences not elsewhere classified / Science Policy
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-28970996
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://dx.doi.org/10.6084/m9.figshare.c.7146579.v1

Abstract Background The complex management of health needs in multimorbid patients, alongside limited cost data, presents challenges in developing cost-effective patient-care pathways. We estimated the costs of managing 171 dyads and 969 triads in Belgium, taking into account the influence of morbidity interactions on costs. Methods We followed a retrospective longitudinal study design, using the linked Belgian Health Interview Survey 2018 and the administrative claim database 2017–2020 hosted by the Intermutualistic Agency. We included people aged 15 and older, who had complete profiles (N = 9753). Applying a system costing perspective, the average annual direct cost per person per dyad/triad was presented in 2022 Euro and comprised mainly direct medical costs. We developed mixed models to analyse the impact of single chronic conditions, dyads and triads on healthcare costs, considering two-/three-way interactions within dyads/triads, key cost determinants and clustering at the household level. Results ...